Literature DB >> 18996964

Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus.

Ippei Kanazawa1, Toru Yamaguchi, Masahiro Yamamoto, Mika Yamauchi, Shozo Yano, Toshitsugu Sugimoto.   

Abstract

BACKGROUND: Although, adiponectin might be associated with bone metabolism, the relationships between serum adiponectin and bone mineral density (BMD) as well as vertebral fracture in type 2 diabetes are still unclear. OBJECTIVE AND METHODS: We investigated the relationships between each of serum total and high molecular weight (HMW) adiponectin versus BMD, bone markers, and the presence of vertebral fractures in a total of 231 men and 170 post-menopausal women with type 2 diabetes.
RESULTS: Multiple regression analysis adjusted for age, duration of diabetes, BMI, serum creatinine, and HbA(1c) showed that serum total adiponectin was negatively correlated with BMD at the total, lumbar spine, and femoral neck (r=-0.165, P<0.05; r=-0.187, P<0.05; and r=-0.136, P<0.05 respectively) and positively with urinary N-terminal cross-linked telopeptide of type-I collagen in men (r=0.148, P<0.05), and that serum HMW adiponectin was negatively correlated with BMD at the lumbar spine (r=-0.146, P<0.05). Multivariate logistic regression analysis adjusted for the parameters described above showed that total adiponectin was associated with the presence of vertebral fractures in men (odds ratio (OR)=1.396, 95% confidential interval (CI) 1.020-1.911 per s.d. increase, P<0.05), and both total and HMW adiponectin were associated with moderate or severe vertebral fractures (OR=1.709, 95% CI 1.048-2.787 per s.d. increase, P<0.05 and OR=1.810, 95% CI 1.112-2.946 per s.d. increase, P<0.05 respectively), but not in post-menopausal women.
CONCLUSIONS: Serum adiponectin could be associated with BMD and turnover and clinically useful for assessing the risk of vertebral fractures in type 2 diabetic men.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18996964     DOI: 10.1530/EJE-08-0642

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  33 in total

Review 1.  Type 2 diabetes and bone fractures.

Authors:  Kendall F Moseley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

2.  Adiponectin is associated with bone strength and fracture history in paralyzed men with spinal cord injury.

Authors:  C O Tan; R A Battaglino; A L Doherty; R Gupta; A A Lazzari; E Garshick; R Zafonte; L R Morse
Journal:  Osteoporos Int       Date:  2014-07-01       Impact factor: 4.507

Review 3.  Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory Component.

Authors:  Reuven Mader; Nicola Pappone; Xenofon Baraliakos; Iris Eshed; Piercarlo Sarzi-Puttini; Fabiola Atzeni; Amir Bieber; Irina Novofastovski; David Kiefer; Jorrit-Jan Verlaan; Pasquale Ambrosino; Dan Buskila; Jacome Bruges Armas; Muhammad Asim Khan
Journal:  Curr Rheumatol Rep       Date:  2021-01-26       Impact factor: 4.592

4.  Relationship between serum adiponectin and bone mineral density in male patients with obstructive sleep apnea syndrome.

Authors:  Dong-Dong Chen; Jie-Feng Huang; Qi-Chang Lin; Gong-Ping Chen; Jian-Ming Zhao
Journal:  Sleep Breath       Date:  2017-03-25       Impact factor: 2.816

5.  Serum adiponectin levels in patients with diffuse idiopathic skeletal hyperostosis (DISH).

Authors:  Reuven Mader; I Novofastovski; N Schwartz; E Rosner
Journal:  Clin Rheumatol       Date:  2018-08-18       Impact factor: 2.980

6.  A cross-sectional study of the association between adipokine levels and bone mineral density according to obesity and menopausal status in Korean women.

Authors:  Ji-Hee Haam; Young-Sang Kim; Moon Jong Kim; Hyung Suk Koo; Hyung Yuk Kim; Hye-Jung Kim; Ki Hyun Park; Nam-Seok Joo; Kyung-Chae Park
Journal:  J Bone Miner Metab       Date:  2016-11-21       Impact factor: 2.626

Review 7.  New understanding and treatments for osteoporosis.

Authors:  G Mazziotti; J Bilezikian; E Canalis; D Cocchi; A Giustina
Journal:  Endocrine       Date:  2012-02       Impact factor: 3.633

8.  Serum adiponectin and bone mineral density in male hemodialysis patients.

Authors:  S Okuno; E Ishimura; K Norimine; N Tsuboniwa; S Kagitani; K Yamakawa; T Yamakawa; K K Sato; T Hayashi; S Shoji; Y Nishizawa; M Inaba
Journal:  Osteoporos Int       Date:  2011-09-17       Impact factor: 4.507

Review 9.  Osteocalcin as a hormone regulating glucose metabolism.

Authors:  Ippei Kanazawa
Journal:  World J Diabetes       Date:  2015-12-25

10.  Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry.

Authors:  Yuji Komorita; Masanori Iwase; Hiroki Fujii; Toshiaki Ohkuma; Hitoshi Ide; Tamaki Jodai-Kitamura; Akiko Sumi; Masahito Yoshinari; Udai Nakamura; Dongchon Kang; Takanari Kitazono
Journal:  Diabetologia       Date:  2017-07-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.